Bosentan-based, treat-to-target therapy in patients with pulmonary arterial hypertension: results from the COMPASS-3 study

The phase 4 COMPASS-3 study evaluated whether a singular endpoint produces clinically meaningful outcomes in patients with pulmonary arterial hypertension (PAH). The relationship between cardiac magnetic resonance imaging (cMRI)-derived parameters and right heart catheterization (RHC) measurements w...

Descripción completa

Detalles Bibliográficos
Autores principales: Benza, Raymond L., Raina, Amresh, Gupta, Himanshu, Murali, Srinivas, Burden, Annie, Zastrow, Michael S., Park, Myung H., Simon, Marc A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798685/
https://www.ncbi.nlm.nih.gov/pubmed/29064349
http://dx.doi.org/10.1177/2045893217741480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798685/
https://www.ncbi.nlm.nih.gov/pubmed/29064349
http://dx.doi.org/10.1177/2045893217741480

Ejemplares similares